Companies /Healthcare

Cytokinetics Inc

NASDAQ: CYTK Biotechnology
$72.23
▼ $5.67 (−7.28%) today
Markets open · 2:22pm ET
24/7 Rating BUY
12-Month Price Target
$127.70 +77.0% upside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $72.14
Street consensus $109.90
Ours vs. the Street +16.2%
$98.90Conservative$72.14Current$127.70Our Target$141.47Optimistic
12-Month Projection Historical Optimistic Target Conservative
$60$90$120Aug 2025Aug 2027Today$141.47$127.70$98.90
$60$90$120Aug 2025Aug 2027Today$141.47$127.70$98.90

Analyst Sentiment

22ANALYSTS
Buy2091%
Hold29%
Sell00%
The Bottom Line

Cytokinetics appears attractively valued at current levels. With a 77.0% upside to our $127.70 target, the risk-reward profile looks favorable for investors with a 12-month time horizon. Wall Street agrees, with 91% of analysts rating it a Buy.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Strong analyst consensus (bullish)
+5.5%
Volatility Adjustment
Lower volatility stock
+1.2%
Price Position
Trading near 52-week high
+1.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$80$160$240$320’26’27’28’29’30’31$340.84$341.51$152.35
$80$160$240$320’26’27’28’29’30’31$340.84$341.51$152.35

Prediction History

CYTK Price Target History Our Target Stock Price
$80$100$120Jun 4Aug 21$127.70$76.84
$80$100$120Jun 4Aug 21$127.70$76.84
Date Price Target Stock Price Rating Upside
$127.70 $76.84 BUY +66.2%
$126.48 $74.13 BUY +70.6%
$125.26 $107.80 BUY +16.2%
$125.26 $77.13 BUY +62.4%
$125.26 $81.92 BUY +52.9%
$125.26 $82.07 BUY +52.6%
$125.26 $84.59 BUY +48.1%
$125.16 $86.49 BUY +44.7%

Frequently Asked Questions

What is the CYTK stock price prediction for 2030?

Looking ahead to 2030, our model projects CYTK could trade at an average price of $250.24, with a potential range between $187.68 and $312.80. This represents a potential 246.9% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is CYTK a buy, sell, or hold right now?

24/7 Wall St. currently rates CYTK as a BUY. Strong upside (+77.0%) Among Wall Street analysts, 20 rate it Buy, 2 rate it Hold, and 0 rate it Sell.

What is the CYTK stock price target in an optimistic scenario?

In our optimistic scenario for CYTK, the stock could reach $141.47 over the next 12 months, representing a 96.1% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.

What is the downside risk for CYTK stock?

Our conservative scenario for CYTK projects a price of $98.90 over the next 12 months (37.1% from current levels), suggesting relatively limited downside if headwinds materialize. No forecast is a guarantee. Position sizing and time horizon still matter.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →